Related Experiment Videos
Acute promyelocytic leukemia developing in untreated essential thrombocythemia
Naoaki Sato1, Tatsuo Furukawa, Masayoshi Masuko
1First Department of Internal Medicine, Niigata University of School of Medicine, Niigata, Japan.
American Journal of Hematology
|September 28, 2002
Summary
This study reports the first case of acute promyelocytic leukemia transformation in Philadelphia chromosome-negative essential thrombocythemia. The patient experienced multiple relapses despite treatment, including stem cell transplantation.
Area of Science:
- Hematology
- Oncology
Background:
- Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
- Transformation of ET to acute myeloid leukemia (AML) is rare, particularly the promyelocytic variant.
Observation:
- A patient with untreated ET developed the microgranular variant of acute promyelocytic leukemia (APL) 9 years after ET diagnosis.
- The patient achieved complete remission (CR) but experienced early relapse.
- A second CR was achieved followed by allogeneic peripheral stem cell transplantation, with subsequent relapse involving meningeal infiltration.
Findings:
- This is the first reported case of promyelocytic transformation in Philadelphia chromosome-negative, untreated ET.
- The transformation was confirmed by the presence of both t(15;17) translocation and PML-RAR alpha fusion gene.
- The review includes other cases of promyelocytic transformation in myeloproliferative diseases (MPD) excluding chronic myeloid leukemia (CML).
Implications:
- This case highlights a rare but aggressive complication of ET.
- Understanding the mechanisms of leukemic transformation in MPD is crucial for developing targeted therapies.
- Further research is needed to elucidate the specific pathways leading to APL transformation in ET.